Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07701590 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs

Study acronym: CAMPR-II
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Capsicure, LLC
5 trials monitored
See all monitored trials
Diabetes
5,087 trials monitored
See 222 trials at risk
CAMPR-II Trial: A multicenter hybrid platform trial comparing the effects of a prospective cohort treated with a saline-hydrated allogeneic dual-layer amniotic membrane product or a synthetic, resorbable polymeric wound matrix to a coarsened exact matched retrospective control cohort of patients with hard-to-heal DFUs and VLUs
Trial Details
NCT Number NCT07701590
Lead Sponsor Capsicure, LLC
Collaborators: BioLab Holdings
Conditions
(from sponsor)		 Wound, Foot, Diabetic Foot Ulcer (DFU), Venus Leg Ulcer
Related terms Diabetic Foot, Foot Injuries
Enrollment 147 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov